Otolaryngology Doctors in High Point, NC Accepting Medicare

5 Otolaryngology doctors found. Showing 1 - 5

Dr. Frank Burton, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 717 Dorado Cir, High Point, NC 27265 Phone: 336-880-9317

William Arnold Pincus, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 624 Quaker Ln, Ste 208c, High Point, NC 27262 Phone: 336-802-2085    Fax: 336-802-2086

Robert F. Leinbach Ii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 624 Quaker Ln, Suite 208c, High Point, NC 27262 Phone: 336-802-2085    Fax: 336-802-2086

David F. Moore Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4515 Premier Dr Ste 404, High Point, NC 27265 Phone: 336-802-2085    Fax: 336-802-2086

Carl David Phipps, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 624 Quaker Ln, Suite 208c, High Point, NC 27262 Phone: 336-802-2085    Fax: 336-802-2086

News Archive

S&P downgrade puts pressure on 'super committee' to fix entitlements

"S&P sees the debt agreement as falling short of what's necessary to fix the nation's finances. The spending cuts Democrats and Republicans agreed on were relatively modest".

Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product

ZIOPHARM Oncology, Inc., an oncology small molecule and synthetic biology drug development company, and Solasia Pharma K.K., a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today that they have entered into a license and collaboration agreement to develop and commercialize ZIOPHARM's darinaparsin product and related organic arsenic molecules in specified Pan-Asian/Pacific territories.

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS® (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.

Study finds increasing death rates from heart disease in young women

A nationwide US study has found increasing death rates from heart disease in women under 65. The research is published in European Heart Journal - Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC).

Read more Medical News

› Verified 8 days ago